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OZONE APPLICATION IN COMPLEX
TREATMENT OF PYOINFLAMMATORY
COMPLICATIONS IN PATIENTS WITH
DIABETES MELLITUS
Abstract. Ozone application in a complex treatment of patients with
diabetes complicated by pyoinflammatory processes has an apparent
therapeutic effect and prevents the development of the relapse and
complications of the disease promoting significant improvements of
direct and remote results of treatment of the given pathology.
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Introduction
Scientific data analysis shows a steady increase in
the number of patients with diabetes, and in developed
countries reaches more than 6% of the population [2, 5].
From the surgical point of view, topicality of this
problem is first of all stipulated by the fact that purulent-
necrotic processes develop in more than 30-70% diabet-
ic patients and 50% of hospitalized patients need surgi-
cal care concerning these complications [1, 3, 4].
With regard of to the mentioned facts, it becomes
evident that the effective methods of complex treatment
of purulent processes in diabetic patients should be
searched in order to introduce into clinical practice the
effective methods of conservative treatment and new
ways of reparative processes activation. For this pur-
pose ozonotherapy has recently become widely used.
The aim of research
To improve the treatment results of pyoinflammato-
ry processes in patients with diabetes through the use of
intravenous ozonotherapy.
Material and method
124 diabetic patients with pyoinflammatory complica-
tions have been examined. The main group - 53 (42.7%)
patients, along with comprehensive treatment underwent
intravenous ozone therapy. The control group -71 (57.2%)
patients were treated by conventional methods.
Intravenous administration of ozonized physiological
solution was performed in all patients of the main group,
along with traditional therapy, similar in composition to
the control group of patients [6]. Coagulogram indices,
lipid peroxidation, parameters were determined.
Discussion of results
According to some authors, in diabetic patients with
pyoinflammatory lesion of soft tissues the level of lip-
id peroxidation end product – malonic aldehyde in the
wound increases. Inhibition of AOP manifests by a sig-
nificant decrease in tissue retinol and tocopherol in par-
ticular, as well as decreased activity of glutathione re-
ductase. The most effective treatment methods in terms
of lipid peroxidation stabilization are those including
ultraviolet blood irradiation, low-intensity laser irradi-
ation and sorbents application [2, 6].
Hypercoagulation syndrome vith microthromboses
development and whieh is manifested by is pathogno-
monic an increased thrombocytes aggregation activity.
Combined with decreased anticoagulant and fibrinolyt-
ic blood activity it stipulates the widespread use of re-
ocorrectors together with anticoagulants and antiag-
gregants [6].
The results of the coagulogram study in diabetic
patients with pyoinflammatory complications (Table 1)
showed that in the control group of patients on admis-
sion, during the treatment and at discharge significant
changes were not detected concerning to the prothrom-
bin index, recalcification time, thrombin time, hemat-
ocrit, and fibrinogen. In the context of ozone therapy
application in the main group of patients on admission,
during the treatment and at discharge the significant
coagulogram parameters changes were not revealed.
These changes against a background of typical pos-
itive clinical effects of ozone therapy can be regarded as
a favourable signs of coagulogram parameters for the
application of this method of treatment in diabetic pa-
tients with pyoinflammatory complications.
The analysis of lipid peroxidation indices, AOP, OPM
parameters in diabetic patients with pyoinflammatory
complications (Table 2) showed that in the control group
of patients on admission, during the treatment and at dis-
charge significant changes were not detected as to the
activity of AOP factor – ceruloplasmin, lipid peroxidation
product – malonic aldehyde and OPM. In the context of
ozone therapy application in the main group of patients
on admission, during the treatment and at discharge the
parameters were not considerably changed either.
In our opinion the coagulogram parameters, lipid
peroxidation, AOP, OPM indices against the back-
ground of typical positive clinical effects of ozone ther-
apy application can be regarded as favorable biochemi-
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cal signs for the use of the given method of treatment in
diabetic patients with pyoinflammatory complications.
Conclusions
1. Implementation of the positive effects of ozone
therapy in the clinic in diabetic patients with pyoinflam-
matory complications is not accompanied by the devel-
opment of damage reactions on the level of hemostasis
parameters and blood biochemical parameters.
2. The above mentioned fact confirms the expedien-
cy of intravenous ozone therapy application clinically
in this category of patients.
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